SCHEMBL1679968

SCHEMBL1679968

CCC(O)(S)OC(C)OC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679877 0.80
SCHEMBL5162350 0.80 LMNA (0.52) LMNA
SCHEMBL7531384 0.77 LMNA (0.32) LMNA
SCHEMBL7027455 0.70 LMNA (0.30) LMNA
SCHEMBL300519 0.69 ALDH1A1 (0.46)
SCHEMBL8496130 0.66
SCHEMBL1061722 0.65
SCHEMBL22494580 0.65 ALDH1A1 (0.31)
Alcohol SCHEMBL2204414 0.63
Tert-Butanol SCHEMBL9765186 0.63 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4659736-A1 HAIR-SHAPE-IMPARTING METHOD Kao Corporation (JP) 2025-12-10 EP disclosed
WO-2024162257-A1 HAIR-SHAPE-IMPARTING METHOD 花王株式会社 2024-08-08 WO disclosed
EP-2659879-B1 HAIR TREATMENT AGENT COMPOSITION KAO CORP (JP) 2020-06-10 EP disclosed
EP-2482789-B1 HAIR TREATMENT COMPOSITION COMPRISING POLYOXYALKYLENE ALKYL ETHER KAO CORP (JP) 2018-04-25 EP disclosed
US-9868793-B2 Cationic group-containing cellulose ether KAO CORPORATION (JP) 2018-01-16 US disclosed
EP-3010591-B1 CATIONIC GROUP-CONTAINING CELLULOSE ETHER KAO CORP (JP) 2017-04-12 EP disclosed
US-9458249-B2 Cellulose ether containing cationic group KAO CORPORATION (JP) 2016-10-04 US disclosed
EP-2894170-B1 CELLULOSE ETHER CONTAINING CATIONIC GROUP KAO CORP (JP) 2016-09-28 EP disclosed
US-20160122441-A1 CATIONIC GROUP-CONTAINING CELLULOSE ETHER KAO CORPORATION (JP) 2016-05-05 US disclosed
EP-3010591-A1 CATIONIC GROUP-CONTAINING CELLULOSE ETHER Kao Corporation (JP) 2016-04-27 EP disclosed
WO-2011040632-A2 HAIR TREATMENT COMPOSITION KAO CORPORATION (JP) 2011-04-07 WO disclosed
US-20070248554-A1 Hair Style Control Agent KAO CORPORATION (JP) 2007-10-25 US disclosed
EP-1752130-A1 HAIR STYLE CONTROL AGENT Kao Corporation (JP) 2007-02-14 EP disclosed
EP-0658338-B1 Straightening curly hair using compositions comprising keratin reducing substances and alcohols KAO CORP (JP) 2004-03-24 EP disclosed
US-20020146380-A1 For removal of body hairs and is decreased in odor KAO CORPORATION (JP) 2002-10-10 US disclosed
US-6156077-A Hair cosmetic composition comprising an oxyalkylenized xanthan gum KAO CORPORATION (JP) 2000-12-05 US disclosed
US-5958084-A CONSISTS OF AN OXIDATION DYE PRECURSOR, A COUPLER AND AN OXYALKYLENIZED XANTHANE GUM, AND A SALT OF INORGANIC ACID OR ORGANIC ACID KAO CORPORATION (JP) 1999-09-28 US disclosed
EP-0784970-A2 Hair cosmetic composition Kao Corporation (JP) 1997-07-23 EP disclosed
US-5609860-A Curly hair-straightening composition KAO CORPORATION (JP) 1997-03-11 US disclosed
EP-0658338-A1 Curly hair-straightening composition comprising keratin reducing substances and alcohols KAO CORPORATION (JP) 1995-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122441-A1 CATIONIC GROUP-CONTAINING CELLULOSE ETHER CUTA, UGCG, UGT8 LMNA 2524/4885
US-20070248554-A1 Hair Style Control Agent KRT18, S100A4, S100A10 LMNA 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.